Regulatory Approval to sell Xprecia PrimeTM in 32 countries in Europe -- MEDICA - World Forum for Medicine

28.02.2022

Universal Biosensors Pty. Ltd.

Regulatory Approval to sell Xprecia PrimeTM in 32 countries in Europe

Universal Biosensors, Inc. (ASX:UBI) is pleased to announce it has been granted regulatory approval to sell its next generation handheld PT/INR coagulation testing platform, Xprecia PrimeTM, in 32 countries across Europe.

Exhibitor Data Sheet